Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SKINOVATION PHARMACEUTICAL INC | Financial_Report.xls |
| 10-Q - FORM 10-Q - SKINOVATION PHARMACEUTICAL INC | skin0505form10q.htm |
| EX-31.2 - EXHIBIT 31.2 - SKINOVATION PHARMACEUTICAL INC | skin0505form10qex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - SKINOVATION PHARMACEUTICAL INC | skin0505form10qex31_1.htm |
Exhibit 32.1
SKINOVATION PHARMACEUTICAL INCORPORATED
CERTIFICATION OF PERIODIC REPORT
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
18 U.S.C. Section 1350
The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
| a. | the quarterly report on Form 10-Q of Skinovation Pharmaceutical Incorporated for the quarter ended March 13, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| b. | the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Skinovation Pharmaceutical Incorporated. |
| Date: May 7, 2014 | /s/ Hugo Rodier |
| Hugo Rodier | |
| Principal Executive Officer | |
| Principal Financial Officer |